EcoDrugPlus

Ensembl ID : ENSELUG00000028090
Gene Symbol: -
Cross references: -
318 Possible Orthologues:

Ensembl ID : ENSELUG00000030777
Gene Symbol: -
Cross references: -
157 Possible Orthologues:

Ensembl ID : ENSELUG00000032602
Gene Symbol: -
Cross references: -
157 Possible Orthologues:

Ensembl ID : ENSELUG00000001295
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSELUG00000032646
Gene Symbol: -
Cross references: -
184 Possible Orthologues:

Ensembl ID : ENSELUG00000032734
Gene Symbol: -
Cross references: -
151 Possible Orthologues:

Ensembl ID : ENSELUG00000021298
Gene Symbol: -
Cross references: -
304 Possible Orthologues:

Ensembl ID : ENSELUG00000011593
Gene Symbol: RPS8A
1 Cross references
327 Possible Orthologues:

Ensembl ID : ENSELUG00000016668
Gene Symbol: -
Cross references: -
304 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).